| 1 |
34907086 | Resistance Profile and Structural Modeling of Next-Generation ROS1 Tyrosine Kinase Inhibitors. | 2022 Feb |
1 |
| 2 |
33196586 | Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma. | 2021 Apr 1 |
2 |
| 3 |
32923114 | ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer. | 2020 May 6 |
3 |
| 4 |
33324391 | ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1-SHP2 Signaling Pathway in Non-Small Cell Lung Cancer. | 2020 |
1 |
| 5 |
31143519 | Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death. | 2019 |
2 |
| 6 |
31260890 | Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors. | 2019 Oct 1 |
2 |
| 7 |
28717217 | TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity. | 2017 Jul 17 |
2 |
| 8 |
26964870 | Mouse models for ROS1-fusion-positive lung cancers and their application to the analysis of multikinase inhibitor efficiency. | 2016 May |
1 |
| 9 |
25351743 | Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer. | 2015 Jan 1 |
3 |
| 10 |
25688157 | Molecular Changes Associated with Acquired Resistance to Crizotinib in ROS1-Rearranged Non-Small Cell Lung Cancer. | 2015 May 15 |
1 |
| 11 |
23418494 | Mouse model for ROS1-rearranged lung cancer. | 2013 |
1 |